FRESENIUS MEDICAL CARE-ADR (FMS)
US3580291066 - ADR
FMS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FMS get a neutral evaluation. Nothing too spectacular is happening here. FMS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
FMS had positive earnings in the past year.
FMS had a positive operating cash flow in the past year.
In the past 5 years FMS has always been profitable.
FMS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
FMS has a Return On Assets of 1.47%. This is in the better half of the industry: FMS outperforms 64.66% of its industry peers.
Looking at the Return On Equity, with a value of 3.66%, FMS is in the better half of the industry, outperforming 67.24% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.53%, FMS is in line with its industry, outperforming 56.90% of the companies in the same industry.
FMS had an Average Return On Invested Capital over the past 3 years of 3.63%. This is below the industry average of 8.59%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 3.66% | ||
| ROIC | 3.53% |
ROA(3y)2.06%
ROA(5y)2.7%
ROE(3y)5.37%
ROE(5y)7.3%
ROIC(3y)3.63%
ROIC(5y)4.66%
1.3 Margins
The Profit Margin of FMS (2.57%) is better than 69.83% of its industry peers.
FMS's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.12%, FMS is in the better half of the industry, outperforming 76.72% of the companies in the same industry.
FMS's Operating Margin has declined in the last couple of years.
FMS has a Gross Margin (25.32%) which is in line with its industry peers.
In the last couple of years the Gross Margin of FMS has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.12% | ||
| PM (TTM) | 2.57% | ||
| GM | 25.32% |
OM growth 3Y-19.4%
OM growth 5Y-14%
PM growth 3Y-26.73%
PM growth 5Y-26.52%
GM growth 3Y-6.53%
GM growth 5Y-4.06%
2. Health
2.1 Basic Checks
FMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, FMS has about the same amount of shares outstanding.
Compared to 5 years ago, FMS has less shares outstanding
The debt/assets ratio for FMS has been reduced compared to a year ago.
2.2 Solvency
FMS has an Altman-Z score of 1.58. This is a bad value and indicates that FMS is not financially healthy and even has some risk of bankruptcy.
FMS's Altman-Z score of 1.58 is in line compared to the rest of the industry. FMS outperforms 48.28% of its industry peers.
FMS has a debt to FCF ratio of 6.28. This is a slightly negative value and a sign of low solvency as FMS would need 6.28 years to pay back of all of its debts.
The Debt to FCF ratio of FMS (6.28) is better than 68.10% of its industry peers.
FMS has a Debt/Equity ratio of 0.80. This is a neutral value indicating FMS is somewhat dependend on debt financing.
FMS's Debt to Equity ratio of 0.80 is in line compared to the rest of the industry. FMS outperforms 42.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | 6.28 | ||
| Altman-Z | 1.58 |
ROIC/WACC0.79
WACC4.46%
2.3 Liquidity
A Current Ratio of 1.42 indicates that FMS should not have too much problems paying its short term obligations.
FMS has a Current ratio (1.42) which is comparable to the rest of the industry.
A Quick Ratio of 1.07 indicates that FMS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.07, FMS is in line with its industry, outperforming 40.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
The earnings per share for FMS have decreased strongly by -17.23% in the last year.
FMS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.60% yearly.
The Revenue has been growing slightly by 0.29% in the past year.
FMS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.29% yearly.
EPS 1Y (TTM)-17.23%
EPS 3Y-17.86%
EPS 5Y-9.6%
EPS growth Q2Q2.33%
Revenue 1Y (TTM)0.29%
Revenue growth 3Y2.89%
Revenue growth 5Y3.29%
Revenue growth Q2Q-0.18%
3.2 Future
FMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.93% yearly.
Based on estimates for the next years, FMS will show a small growth in Revenue. The Revenue will grow by 5.01% on average per year.
EPS Next Y9.26%
EPS Next 2Y17.17%
EPS Next 3Y17.12%
EPS Next 5Y15.93%
Revenue Next Year1.88%
Revenue Next 2Y2.9%
Revenue Next 3Y3.33%
Revenue Next 5Y5.01%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FMS is valuated correctly with a Price/Earnings ratio of 14.67.
FMS's Price/Earnings ratio is rather cheap when compared to the industry. FMS is cheaper than 86.21% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 24.84. FMS is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 13.38, which indicates a correct valuation of FMS.
Based on the Price/Forward Earnings ratio, FMS is valued cheaply inside the industry as 83.62% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of FMS to the average of the S&P500 Index (21.35), we can say FMS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.67 | ||
| Fwd PE | 13.38 |
4.2 Price Multiples
93.10% of the companies in the same industry are more expensive than FMS, based on the Enterprise Value to EBITDA ratio.
FMS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FMS is cheaper than 93.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.74 | ||
| EV/EBITDA | 6.6 |
4.3 Compensation for Growth
FMS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as FMS's earnings are expected to grow with 17.12% in the coming years.
PEG (NY)1.58
PEG (5Y)N/A
EPS Next 2Y17.17%
EPS Next 3Y17.12%
5. Dividend
5.1 Amount
FMS has a Yearly Dividend Yield of 3.15%.
Compared to an average industry Dividend Yield of 2.73, FMS pays a better dividend. On top of this FMS pays more dividend than 93.97% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, FMS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.15% |
5.2 History
The dividend of FMS has a limited annual growth rate of 1.12%.
FMS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.12%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
65.86% of the earnings are spent on dividend by FMS. This is not a sustainable payout ratio.
The dividend of FMS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP65.86%
EPS Next 2Y17.17%
EPS Next 3Y17.12%
FRESENIUS MEDICAL CARE-ADR
NYSE:FMS (4/26/2024, 7:04:00 PM)
After market: 20.1 0 (0%)20.1
-0.11 (-0.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.80B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.15% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.67 | ||
| Fwd PE | 13.38 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.58
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 3.66% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 7.12% | ||
| PM (TTM) | 2.57% | ||
| GM | 25.32% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.8 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.42 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-17.23%
EPS 3Y-17.86%
EPS 5Y
EPS growth Q2Q
EPS Next Y9.26%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)0.29%
Revenue growth 3Y2.89%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y